NEW YORK (GenomeWeb) – SkylineDx said today that it is collaborating with the Mayo Clinic to develop new diagnostic tests to improve clinical decision-making for melanoma patients.

The company said that it is lending its expertise in informatics to help optimize and further develop an algorithm — originally discovered and developed by Mayo Clinic dermatologist Alexander Meves — that identifies risk factors associated with metastasis.